Back to News
Market Impact: 0.3
Corxel US To Go Public Through SPAC Merger With Amanat Acquisition
Source: Nasdaq
M&A & RestructuringHealthcare & BiotechIPOs & SPACs
Corxel US and Amanat Acquisition Corp. (AMAN) signed a definitive merger agreement to create a publicly listed biopharmaceutical company focused on obesity treatments. The article provides no deal value, transaction terms, or expected closing date.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
AMAN0.65
More News
- From Wall Street to Silicon Valley, Anthropic IPO poised to have massive 'trickle-down effect'
- Anthropic’s IPO filing shows explosive growth, risks and staggering costs
- EQT becomes the nation’s leading natural gas ‘juggernaut’ with a $13B deal as data center, export demand surges
- Microsoft offers buyouts to nearly 30% of workforce in ongoing AI shift
- Anthropic Files for IPO While Warning of ‘Catastrophic’ AI Risks
- Anthropic’s risk factors include the end of humanity, a feud with the Pentagon, and CEO Dario Amodei’s reputation